文献速递浆细胞疾病

在单细胞水平刻画免疫微环境在多发性骨髓瘤进展中的作用

Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level.
PubMed 文献 · Blood Adv · 2022-01-01

该研究采用单细胞RNA测序分析骨髓细胞,样本来自意义未明的单克隆丙种球蛋白病、冒烟型多发性骨髓瘤和新诊断多发性骨髓瘤等前驱及进展阶段,并结合既往发表的数据集进行联合分析。尽管患者间异质性极大,两个数据集均一致观察到随疾病进展记忆和初始CD4 T细胞大幅减少、CD8+效应T细胞和调节性T细胞增加,以及非克隆性记忆B细胞富集和CD14、CD16单核细胞增多。

要点

  • 随疾病进展,记忆和初始CD4 T细胞大幅减少,CD8+效应T细胞和调节性T细胞增加。
  • 与前期阶段相比,多发性骨髓瘤中非克隆性记忆B细胞富集,CD14和CD16单核细胞增多。
  • 尽管患者间异质性极大,两个数据集均一致观察到上述免疫改变。

核心结论

  • 这些结果提供了与进展至临床多发性骨髓瘤相关的免疫变化的关键信息,有助于制定基于免疫的患者分层和早期治疗干预策略。

研究设计与样本

  • 研究对来自前驱阶段、意义未明的单克隆丙种球蛋白病、冒烟型多发性骨髓瘤和新诊断多发性骨髓瘤的骨髓细胞进行单细胞RNA测序,并结合既往发表的、使用相似患者人群和样本处理方式的数据集进行分析。

主要发现

  • 随疾病进展,记忆和初始CD4 T细胞大幅减少,CD8+效应T细胞和调节性T细胞增加。
  • 与前期阶段相比,多发性骨髓瘤中非克隆性记忆B细胞富集,CD14和CD16单核细胞增多。
  • 尽管患者间异质性极大,两个数据集均一致观察到上述改变。

局限性

  • 原文报告患者间存在极大异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Early alterations within the bone marrow microenvironment that contribute to the progression of multiple myeloma (MM) from its precursor stages could be the key to identifying novel therapeutic approaches. However, the intrinsic variability in cellular populations between patients and the differences in sample processing and analysis methods have made it difficult to identify consistent changes between data sets. Here, we used single-cell RNA sequencing of bone marrow cells from precursor stages, monoclonal gammopathy of unknown significance, smoldering MM, and newly diagnosed MM and analyzed our data in combination with a previously published data set that used a similar patient population and sample processing. Despite the vast interpatient heterogeneity, some alterations were consistently observed in both data sets. We identified changes in immune cell populations as the disease progressed, which were characterized by a substantial decrease in memory and naïve CD4 T cells, and an increase in CD8+ effector T cells and T-regulatory cells. These alterations were further accompanied by an enrichment of nonclonal memory B cells and an increase in CD14 and CD16 monocytes in MM compared with its precursor stages. These results provide crucial information on the immune changes associated with the progression to clinical MM and can help to develop immune-based strategies for patient stratification and early therapeutic intervention.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Schinke C, Poos AM, Bauer M, et al. Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level. Blood Adv. 2022. PMID: 35977111. doi:10.1182/bloodadvances.2022007217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。